Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular 
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
SpaceX Stock Plunges 16% as KeyBanc Warns Valuation May Be Overstretched 
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
NHTSA Investigates Fatal Tesla Model 3 Crash in Texas Amid Ongoing Autopilot and FSD Safety Scrutiny 
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets 
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge 
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates 
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics 
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
 Shares Announced by Shareholders Foundation - EconoTimes)
SAN DIEGO, Jan. 27, 2016 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York on behalf of certain investors who purchased of shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) over alleged Securities Laws Violations by Anavex Life Sciences.
Investors who purchased shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) have certain options and for certain investors are short and strict deadlines running. Deadline: February 29, 2016. (NASDAQ:AVXL) investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff claims that the defendants made certain allegedly false and/or misleading statements and/or allegedly failed to disclose that Anavex had used a paid stock promoter to artificially inflate the Company’s share price and that as a result of the foregoing, Anavex’s public statements were materially false and misleading at all relevant times.
On December 29, 2015, Anavex Life Sciences Corp. disclosed that it had received a subpoena from the U.S. Securities and Exchange Commission (“SEC”) on December 22, 2015. Anavex Life Sciences Corp. stated, in part, that "[t]he Company believes the subpoena and investigation relate to the recent unusual activity in the market for the Company's shares."
On December 30, 2015, a report was published entitled “Anavex: A Regulatory Target Damaged By Incriminating Evidence.”
Those who purchased (NASDAQ:AVXL) shares have certain options and should contact the Shareholders Foundation, Inc. by e-mail at [email protected] or call +1 (858) 779-1554.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
